Vascular endothelial growth factor (VEGF) -A, -C and VE-cadherin as potential biomarkers in early breast cancer patients

The impact of VEGF on cancer metastasis and systemic disease

(2022) Yunlong Yang et al.   SEMINARS IN CANCER BIOLOGY

How VEGF-A and its splice variants affect breast cancer development – clinical implications

(2022) Hivin Al Kawas et al.   CELLULAR ONCOLOGY

Circulating proteins as predictive and prognostic biomarkers in breast cancer

(2022) Hugo Veyssière et al.   Clinical Proteomics

Can granulysin provide prognostic value in primary breast cancer?

(2022) Jelena Milovanović et al.   PATHOLOGY RESEARCH AND PRACTICE

The Role of the VEGF Family in Coronary Heart Disease

(2021) Yan Zhou et al.   Frontiers in Cardiovascular Medicine

Role of Cadherins in Cancer—A Review

(2020) Ilona Kaszak et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Cancer-Derived VEGF-C Increases Chemokine Production in Lymphatic Endothelial Cells to Promote CXCR2-Dependent Cancer Invasion and MDSC Recruitment

(2019) Jing-Yi Chen et al.   Cancers

Contribution of Angiogenesis to Inflammation and Cancer

(2019) Dolores Aguilar-Cazares et al.   Frontiers in Oncology

The clinical relevance of serum vascular endothelial growth factor (VEGF) in correlation to circulating tumor cells and other serum biomarkers in patients with metastatic breast cancer

(2018) Malgorzata Banys-Paluchowski et al.   BREAST CANCER RESEARCH AND TREATMENT

High serum vascular endothelial growth factor C predicts better relapse-free survival in early clinically node-negative breast cancer

(2018) José Maañón et al.   Oncotarget

Monitoring Serum VEGF in Neoadjuvant Chemotherapy for Patients with Triple‐Negative Breast Cancer: A New Strategy for Early Prediction of Treatment Response and Patient Survival

(2018) Ruo‐Xi Wang et al.   ONCOLOGIST

Predictive role of the overexpression for CXCR4, C-Met, and VEGF-C among breast cancer patients: A meta-analysis

(2016) Fang Wang et al.   BREAST

Cadherin-5: a biomarker for metastatic breast cancer with optimum efficacy in oestrogen receptor-positive breast cancers with vascular invasion

(2016) Simon A Fry et al.   BRITISH JOURNAL OF CANCER

Prognostic Significance of High VEGF-C Expression for Patients with Breast Cancer: An Update Meta Analysis

(2016) Zhiqiao Zhang et al.   PLoS One

VE-Cadherin and Endothelial Adherens Junctions: Active Guardians of Vascular Integrity

(2013) Monica Giannotta et al.   DEVELOPMENTAL CELL

Prognostic significance of VEGF-C immunohistochemical expression in breast cancer: a meta-analysis

(2013) Sheng Gao et al.   TUMOR BIOLOGY

HER2/neu expression correlates with vasculogenic mimicry in invasive breast carcinoma

(2012) Tieju Liu et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Lymphatic microvessel density and vascular endothelial growth factor-C and -D as prognostic factors in breast cancer: a systematic review and meta-analysis of the literature

(2012) Jun Wang et al.   MOLECULAR BIOLOGY REPORTS

Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and Elaboration

(2012) Douglas G. Altman et al.   PLOS MEDICINE

The association between vascular endothelial growth factor expression in invasive breast cancer and survival varies with intrinsic subtypes and use of adjuvant systemic therapy: results from the Nurses’ Health Study

(2011) Ying Liu et al.   BREAST CANCER RESEARCH AND TREATMENT

Serum Vascular Endothelial Growth Factors A, C and D in Human Breast Tumors

(2009) Iwona Gisterek et al.   PATHOLOGY & ONCOLOGY RESEARCH

Vascular Endothelial Cadherin Promotes Breast Cancer Progression via Transforming Growth Factor   Signaling

(2008) M. Labelle et al.   CANCER RESEARCH

High levels of vascular endothelial growth factor and its receptors (VEGFR-1, VEGFR-2, neuropilin-1) are associated with worse outcome in breast cancer

(2008) Sriparna Ghosh et al.   HUMAN PATHOLOGY